Epicutaneous sensitization with protein antigen

Dermatologica Sinica

Volumn 30, Issue 4, 2012, Pages 154-159

  Liu, I Lin ^a   Wang, Li Fang ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

epicutaneous immunotherapy; epicutaneous sensitization; protein antigen; Th immune response

Indexed keywords

ALLERGEN; ANTIGEN; CYTOKINE; TOLL LIKE RECEPTOR;

ASTHMA; ATOPIC DERMATITIS; DENDRITIC CELL; EPICUTANEOUS SENSITIZATION; FOOD ALLERGY; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; METHODOLOGY; MOLECULAR MECHANICS; NONHUMAN; REVIEW; SKIN SENSITIZATION; SUBCUTANEOUS IMMUNOTHERAPY;

EID: 84870889941     PISSN: 10278117     EISSN: 2223330X     Source Type: Journal    
DOI: 10.1016/j.dsi.2012.10.003     Document Type: Review

References (81)

1. F. Berard, J.P. Marty, and J.F. Nicolas Allergen penetration through the skin Eur J Dermatol 13 2003 324 330 (Pubitemid 36963089)
2. S.H. Wakelin Contact urticaria Clin Exp Dermatol 26 2001 132 136 (Pubitemid 32275703)
3. H. Neubauer, M. Rytter, J. Kleine-Tebbe, and U.F. Haustein Protein contact dermatitis induced by isolated delayed-type hypersensitivity to meat proteins Contact Dermatitis 41 1999 113 (Pubitemid 29363842)
4. K. Turjanmaa The role of atopy patch tests in the diagnosis of allergy in atopic dermatitis Curr Opin Allergy Clin Immunol 5 2005 425 428 (Pubitemid 41345311)
5. L.F. Santamaria Babi, L.J. Picker, and M.T. Perez Soler Circulating allergen-reactive T cells from patients with atopic dermatitis and allergic contact dermatitis express the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen J Exp Med 181 1995 1935 1940
6. Y. Teraki, T. Hotta, and T. Shiohara Increased circulating skin-homing cutaneous lymphocyte-associated antigen (CLA)+ type 2 cytokine-producing cells, and decreased CLA+ type 1 cytokine-producing cells in atopic dermatitis Br J Dermatol 143 2000 373 378 (Pubitemid 30650408)
7. C.N. Palmer, A.D. Irvine, and A. Terron-Kwiatkowski Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis Nat Genet 38 2006 441 446
8. L.F. Wang, J.Y. Lin, K.H. Hsieh, and R.H. Lin Epicutaneous exposure of protein antigen induces a predominant Th2-like response with high IgE production in mice J Immunol 156 1996 4077 4082
9. J.M. Spergel, E. Mizoguchi, J.P. Brewer, T.R. Martin, A.K. Bhan, and R.S. Geha Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice J Clin Invest 101 1998 1614 1622 (Pubitemid 28198490)
10. C.H. Huang, I.C. Kuo, H. Xu, Y.S. Lee, and K.Y. Chua Mite allergen induces allergic dermatitis with concomitant neurogenic inflammation in mouse J Invest Dermatol 121 2003 289 293 (Pubitemid 36969902)
11. M. Lehto, M. Koivuluhta, and G. Wang Epicutaneous natural rubber latex sensitization induces T helper 2-type dermatitis and strong prohevein-specific IgE response J Invest Dermatol 120 2003 633 640 (Pubitemid 36344007)
12. M. Tutaj, and M. Szczepanik Epicutaneous (EC) immunization with myelin basic protein (MBP) induces TCRalphabeta+ CD4+ CD8+ double positive suppressor cells that protect from experimental autoimmune encephalomyelitis (EAE) J Autoimmun 28 2007 208 215 (Pubitemid 46754767)
13. N. Nieuwenhuizen, D.R. Herbert, F. Brombacher, and A.L. Lopata Differential requirements for interleukin (IL)-4 and IL-13 in protein contact dermatitis induced by Anisakis Allergy 64 2009 1309 1318
14. D. Laouini, S. Kawamoto, and A. Yalcindag Epicutaneous sensitization with superantigen induces allergic skin inflammation J Allergy Clin Immunol 112 2003 981 987 (Pubitemid 37412069)
15. T. Ouchi, A. Kubo, and M. Yokouchi Langerhans cell antigen capture through tight junctions confers preemptive immunity in experimental staphylococcal scalded skin syndrome J Exp Med 208 2011 2607 2613
16. M. Szczepanik, K. Bryniarski, and M. Tutaj Epicutaneous immunization induces alphabeta T-cell receptor CD4 CD8 double-positive non-specific suppressor T cells that inhibit contact sensitivity via transforming growth factor-beta Immunology 115 2005 42 54 (Pubitemid 40593290)
17. H. Kondo, Y. Ichikawa, and G. Imokawa Percutaneous sensitization with allergens through barrier-disrupted skin elicits a Th2-dominant cytokine response Eur J Immunol 28 1998 769 779 (Pubitemid 28116188)
18. J. Strid, J. Hourihane, I. Kimber, R. Callard, and S. Strobel Disruption of the stratum corneum allows potent epicutaneous immunization with protein antigens resulting in a dominant systemic Th2 response Eur J Immunol 34 2004 2100 2109 (Pubitemid 39256091)
19. R. He, M.K. Oyoshi, H. Jin, and R.S. Geha Epicutaneous antigen exposure induces a Th17 response that drives airway inflammation after inhalation challenge Proc Natl Acad Sci U S A 104 2007 15817 15822 (Pubitemid 350035382)
20. L.F. Wang, H.C. Chiu, C.J. Hsu, C.Y. Liu, Y.H. Hsueh, and S.C. Miaw Epicutaneous sensitization with a protein antigen induces Th17 cells J Dermatol Sci 54 2009 192 197
21. L.C. Wood, S.M. Jackson, P.M. Elias, C. Grunfeld, and K.R. Feingold Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice J Clin Invest 90 1992 482 487
22. M.S. Bynoe, J.T. Evans, C. Viret, and C.A.J. Janeway Epicutaneous immunization with autoantigenic peptides induces T suppressor cells that prevent experimental allergic encephalomyelitis Immunity 19 2003 317 328 (Pubitemid 37153409)
23. M. Szczepanik, M. Tutaj, K. Bryniarski, and B.N. Dittel Epicutaneously induced TGF-beta-dependent tolerance inhibits experimental autoimmune encephalomyelitis J Neuroimmunol 164 2005 105 114 (Pubitemid 40826767)
24. J.Y. Lin, J.S. Chen, and C.J. Hsu Epicutaneous sensitization with protein antigen induces Th9 cells J Invest Dermatol 132 2012 739 741
25. L.F. Wang, C.J. Hsu, S.C. Miaw, H.C. Chiu, C.Y. Liu, and H.S. Yu Cross-priming with an epicutaneously introduced soluble protein antigen generates Tc1 cells Eur J Immunol 36 2006 2904 2911
26. A. Kubo, K. Nagao, and M. Amagai Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases J Clin Invest 122 2012 440 447
27. S. Weidinger, T. Illig, and H. Baurecht Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations J Allergy Clin Immunol 118 2006 214 219 (Pubitemid 43949588)
28. C.S. Moniaga, G. Egawa, and H. Kawasaki Flaky tail mouse denotes human atopic dermatitis in the steady state and by topical application with Dermatophagoides pteronyssinus extract Am J Pathol 176 2010 2385 2393
29. H. Kawasaki, K. Nagao, and A. Kubo Altered stratum corneum barrier and enhanced percutaneous immune responses in filaggrin-null mice J Allergy Clin Immunol 129 2012 1538 1546
30. S. Kezic, G.M. O'Regan, and R. Lutter Filaggrin loss-of-function mutations are associated with enhanced expression of IL-1 cytokines in the stratum corneum of patients with atopic dermatitis and in a murine model of filaggrin deficiency J Allergy Clin Immunol 129 2012 1031 1039
31. A.J. Walley, S. Chavanas, and M.F. Moffatt Gene polymorphism in Netherton and common atopic disease Nat Genet 29 2001 175 178 (Pubitemid 32952654)
32. Y. Vasilopoulos, M.J. Cork, and R. Murphy Genetic association between an AACC insertion in the 3'UTR of the stratum corneum chymotryptic enzyme gene and atopic dermatitis J Invest Dermatol 123 2004 62 66 (Pubitemid 38833464)
33. A. De Benedetto, N.M. Rafaels, and L.Y. McGirt Tight junction defects in patients with atopic dermatitis J Allergy Clin Immunol 127 2011 773 786
34. A. Kubo, K. Nagao, M. Yokouchi, H. Sasaki, and M. Amagai External antigen uptake by Langerhans cells with reorganization of epidermal tight junction barriers J Exp Med 206 2009 2937 2946
35. M.K. Oyoshi, G.F. Murphy, and R.S. Geha Filaggrin-deficient mice exhibit TH17-dominated skin inflammation and permissiveness to epicutaneous sensitization with protein antigen J Allergy Clin Immunol 124 2009 485 493
36. C.A. Herrick, L. Xu, A.N. McKenzie, R.E. Tigelaar, and K. Bottomly IL-13 is necessary, not simply sufficient, for epicutaneously induced Th2 responses to soluble protein antigen J Immunol 170 2003 2488 2495 (Pubitemid 36245638)
37. C.A. Herrick, H. MacLeod, E. Glusac, R.E. Tigelaar, and K. Bottomly Th2 responses induced by epicutaneous or inhalational protein exposure are differentially dependent on IL-4 J Clin Invest 105 2000 765 775 (Pubitemid 30164115)
38. R. He, H.Y. Kim, and J. Yoon Exaggerated IL-17 response to epicutaneous sensitization mediates airway inflammation in the absence of IL-4 and IL-13 J Allergy Clin Immunol 124 2009 761 770
39. D. Laouini, H. Alenius, P. Bryce, H. Oettgen, E. Tsitsikov, and R.S. Geha IL-10 is critical for Th2 responses in a murine model of allergic dermatitis J Clin Invest 112 2003 1058 1066 (Pubitemid 38056321)
40. H. Jin, M.K. Oyoshi, and Y. Le IL-21R is essential for epicutaneous sensitization and allergic skin inflammation in humans and mice J Clin Invest 119 2009 47 60
41. M. Anthoni, G. Wang, C. Deng, H.J. Wolff, A.I. Lauerma, and H.T. Alenius Smad3 signal transducer regulates skin inflammation and specific IgE response in murine model of atopic dermatitis J Invest Dermatol 127 2007 1923 1929 (Pubitemid 47075366)
42. H. Jin, L. Kumar, and C. Mathias Toll-like receptor 2 is important for the T(H)1 response to cutaneous sensitization J Allergy Clin Immunol 123 2009 875 882
43. R. Kahlon, and J.P. Dutz Skin immune responses to peptide and protein antigen are TLR4 independent Cell Immunol 226 2003 116 123 (Pubitemid 38220838)
44. W. Ptak, M. Majewska, and K. Bryniarski Epicutaneous immunization with protein antigen in the presence of TLR4 ligand induces TCR alpha beta+CD4+ T contrasuppressor cells that reverse skin-induced suppression of Th1-mediated contact sensitivity J Immunol 182 2009 837 850
45. S.K. Klimuk, H.M.S.S. Najar, S.C. Semple, S. Aslanian, and J.P. Dutz Epicutaneous application of CpG oligodeoxynucleotides with peptide or protein antigen promotes the generation of CTL J Invest Dermatol 122 2004 1042 1049 (Pubitemid 38581008)
46. D. Laouini, A. Elkhal, A. Yalcindag, S. Kawamoto, H. Oettgen, and R.S. Geha COX-2 inhibition enhances the TH2 immune response to epicutaneous sensitization J Allergy Clin Immunol 116 2005 390 396 (Pubitemid 41096548)
47. 2 receptor CRTH2 is important for allergic skin inflammation after epicutaneous antigen challenge J Allergy Clin Immunol 126 2010 784 790
48. R. Das, J.E. Moss, and E. Robinson Role of macrophage migration inhibitory factor in the Th2 immune response to epicutaneous sensitization J Clin Immunol 31 2011 666 680
49. J. Saegusa, D.K. Hsu, and H.Y. Chen Galectin-3 is critical for the development of the allergic inflammatory response in a mouse model of atopic dermatitis Am J Pathol 174 2009 922 931
50. S. Kawamoto, A. Yalcindag, and D. Laouini The anaphylatoxin C3a downregulates the Th2 response to epicutaneously introduced antigen J Clin Invest 114 2004 399 407 (Pubitemid 39071612)
51. A. Yalcindag, R. He, and D. Laouini The complement component C3 plays a critical role in both Th1 and Th2 responses to antigen J Allergy Clin Immunol 117 2006 1455 1461 (Pubitemid 43795761)
52. H. Matsushima, S. Hayashi, and S. Shimada Skin scratching switches immune responses from Th2 to Th1 type in epicutaneously immunized mice J Dermatol Sci 32 2003 223 230 (Pubitemid 37162697)
53. T. Savinko, A. Lauerma, and S. Lehtimäki Topical superantigen exposure induces epidermal accumulation of CD8+ T cells, a mixed Th1/Th2-type dermatitis and vigorous production of IgE antibodies in the murine model of atopic dermatitis J Immunol 175 2005 8320 8326 (Pubitemid 41798398)
54. J.S. Chen, H.C. Chiu, and C.J. Hsu Low-energy visible light irradiation modulates immune responses induced by epicutaneous sensitization with protein antigen J Invest Dermatol 129 2009 2258 2264
55. S. Nakajima, B.Z. Igyártó, and T. Honda Langerhans cells are critical in epicutaneous sensitization with protein antigen via thymic stromal lymphopoietin receptor signaling J Allergy Clin Immunol 129 2012 1048 1055
56. L. Wang, L.S. Bursch, A. Kissenpfennig, B. Malissen, S.C. Jameson, and K.A. Hogquist Langerin expressing cells promote skin immune responses under defined conditions J Immunol 180 2008 4722 4727
57. S. Bedoui, P.G. Whitney, and J. Waithman Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells Nat Immunol 10 2009 488 495
58. A. Elkhal, M. Pichavant, and R. He CD1d restricted natural killer T cells are not required for allergic skin inflammation J Allergy Clin Immunol 118 2006 1363 1368 (Pubitemid 44854120)
59. R. Furmonaviciene, and F. Shakib The molecular basis of allergenicity: comparative analysis of the three dimensional structures of diverse allergens reveals a common structural motif Mol Pathol 54 2001 155 159 (Pubitemid 32539606)
60. H. Wan, H.L. Winton, and C. Soeller Der p 1 facilitates transepithelial allergen delivery by disruption of tight junctions J Clin Invest 104 1999 123 133 (Pubitemid 29534352)
61. H. Wan, H.L. Winton, and C. Soeller The transmembrane protein occludin of epithelial tight junctions is a functional target for serine peptidases from faecal pellets of Dermatophagoides pteronyssinus Clin Exp Allergy 31 2001 279 294 (Pubitemid 32231861)
62. A.M. Ghaemmaghami, L. Gough, H.F. Sewell, and F. Shakib The proteolytic activity of the major dust mite allergen Der p 1 conditions dendritic cells to produce less interleukin-12: allergen-induced Th2 bias determined at the dendritic cell level Clin Exp Allergy 32 2002 1468 1475 (Pubitemid 35278915)
63. V. Mariani, S. Gilles, and T. Jakob Immunomodulatory mediators from pollen enhance the migratory capacity of dendritic cells and license them for Th2 attraction J Immunol 178 2007 7623 7631 (Pubitemid 46898032)
64. N.A. Barrett, A. Maekawa, O.M. Rahman, K.F. Austen, and Y. Kanaoka Dectin-2 recognition of house dust mite triggers cysteinyl leukotriene generation by dendritic cells J Immunol 182 2009 1119 1128
65. N. Asokananthan, P.T. Graham, and D.J. Stewart House dust mite allergens induce proinflammatory cytokines from respiratory epithelial cells: the cysteine protease allergen, Der p 1, activates protease-activated receptor (PAR)-2 and inactivates PAR-1 J Immunol 169 2002 4572 4578 (Pubitemid 35178236)
66. S.K. Jeong, H.J. Kim, and J.K. Youm Mite and cockroach allergens activate protease-activated receptor 2 and delay epidermal permeability barrier recovery J Invest Dermatol 128 2008 1930 1939 (Pubitemid 352001196)
67. A. Trompette, S. Divanovic, and A. Visintin Allergenicity resulting from functional mimicry of a Toll-like receptor complex protein Nature 457 2009 585 588
68. N. Ng, D. Lam, P. Paulus, G. Batzer, and A.A. Horner House dust extracts have both TH2 adjuvant and tolerogenic activities J Allergy Clin Immunol 117 2006 1074 1081
69. J.M. Spergel, E. Mizoguchi, H. Oettgen, A.K. Bhan, and R.S. Geha Roles of TH1 and TH2 cytokines in a murine model of allergic dermatitis J Clin Invest 103 1999 1103 1111 (Pubitemid 29207243)
70. S. Demehri, M. Morimoto, M.J. Holtzman, and R. Kopanm Skin-derived TSLP triggers progression from epidermal-barrier defects to asthma PLoS Biol 7 2009 e1000067
71. H.S. Akei, E.B. Brandt, and A. Mishra Epicutaneous aeroallergen exposure induces systemic TH2 immunity that predisposes to allergic nasal responses J Allergy Clin Immunol 118 2006 62 69 (Pubitemid 43946489)
72. H.S. Akei, A. Mishra, C. Blanchard, and M.E. Rothenberg Epicutaneous antigen exposure primes for experimental eosinophilic esophagitis in mice Gastroenterology 129 2005 985 994 (Pubitemid 41242689)
73. K.Y. Hsieh, C.C. Tsai, C.H. Wu, and R.H. Lin Epicutaneous exposure to protein antigen and food allergy Clin Exp Allergy 33 2003 1067 1075 (Pubitemid 36976233)
74. J. Strid, J. Hourihane, I. Kimber, R. Callard, and S. Strobel Epicutaneous exposure to peanut protein prevents oral tolerance and enhances allergic sensitization Clin Exp Allergy 35 2005 757 766 (Pubitemid 40961349)
75. J. Strid, R. Callard, and S. Strobel Epicutaneous immunization converts subsequent and established antigen-specific T helper type 1 (Th1) to Th2-type responses Immunology 119 2006 27 35 (Pubitemid 44201153)
76. J. Strid, L.A. Tan, S. Strobel, M. Londei, and R. Callard Epicutaneous immunization with type II collagen inhibits both onset and progression of chronic collagen-induced arthritis PLoS One 18 2007 e387
77. G. Senti, N. Graf, and S. Haug Epicutaneous allergen administration as a novel method of allergen-specific immunotherapy J Allergy Clin Immunol 124 2009 997 1002
78. L. Mondoulet, V. Dioszeghy, M. Ligouis, V. Dhelft, C. Dupont, and P.H. Benhamou Epicutaneous immunotherapy on intact skin using a new delivery system in a murine model of allergy Clin Exp Allergy 40 2010 659 667
79. C. Dupont, N. Kalach, P. Soulaines, S. Legoué-Morillon, H. Piloquet, and P.H. Benhamou Cow's milk epicutaneous immunotherapy in children: a pilot trial of safety, acceptability, and impact on allergic reactivity J Allergy Clin Immunol 125 2010 1165 1167
80. L. Mondoulet, V. Dioszeghy, and T. Larcher Epicutaneous immunotherapy (EPIT) blocks the allergic esophago-gastro-enteropathy induced by sustained oral exposure to peanuts in sensitized mice PLoS One 7 2012 e31967
81. V. Dioszeghy, L. Mondoulet, and V. Dhelft Epicutaneous immunotherapy results in rapid allergen uptake by dendritic cells through intact skin and downregulates the allergen-specific response in sensitized mice J Immunol 186 2011 5629 5637